Harvard Business Review

JUNE 16, 2016

Although US firms had pioneered and dominated the technology for two decades, they were now getting pummeled by cheaper Japanese imports. At the same time, the marketplace has become so fiercely competitive—and investors so demanding—that few are willing to take a flyer on an unproven technology. Killing Ideas Faster.

Technology 8

Technology Venture Capitalist Supply Chain Innovation 8

Harvard Business Review

FEBRUARY 17, 2011

The reason for the interest in in part because the industry has suffered from poor returns on investment over the last decade; indeed, some sectors, including biotechnology, report negative aggregate returns. Because of three significant challenges innovators face in emerging markets: Innovation ecosystems are not well-developed.

Marketing 15

Marketing Venture Capitalist Biotechnology IPO 15

Harvard Business Review

NOVEMBER 15, 2016

Despite the East Coast roots of technology entrepreneurship and venture capital (VC), by the 1990s Silicon Valley had gained a major advantage over the Cambridge-Boston area. This post is one in a series of perspectives by presenters and participants in the 8th Global Drucker Forum. The same underlying technologies (e.g.,

Biotechnology 8

Biotechnology Drucker Software Entrepreneur 8

Harvard Business Review

SEPTEMBER 21, 2018

Fewer than one-third (30%) of respondents to our survey see innovation as one of the top three challenges their company faces in achieving its strategic objectives, and just 21% think that technology trends are a major strategic challenge. We also found that a focus on innovation tends to go hand in hand with longer-term time horizons.

Innovation 10

Innovation Short-term Telecommunications Long-term 10

Harvard Business Review

OCTOBER 26, 2011

Between 2006 and 2008, more than $1 billion venture-capital dollars were channeled into startups focused on solar, wind and biofuel technologies. In the last year, however, early-stage investments in clean energy production technologies have fallen substantially (see the table at the end of this piece for more detail).

Energy 11

Energy Finance IPO Biotechnology 11

Harvard Business Review

MARCH 11, 2014

Start-up companies tend to cluster in industries favored by venture capitalists (like biotechnology or information technology) or ones where there are relatively low barriers to entry (like restaurants). Finally, certain problems are almost custom-made for global giants. Second, the world of start-ups is narrowly focused.

Innovation 8

Innovation Venture Capitalist Company Supply Chain 8

Strategy Driven

NOVEMBER 18, 2019

Globally, the energy sector is valued in excess of $7 trillion and by 2035 it is anticipated that the global demand for energy will increase by as much as 30%. There have also been great leaps forward in biotechnology and even people without investment experience in the industry can find a niche sector to become involved in.

Health Care 67

Health Care Biotechnology Energy Insurance 67

Harvard Business Review

OCTOBER 23, 2014

It’s only recently, though, that advances in information technology have made it possible for predictive tools to access and manipulate big data, and to do so continuously — accelerating the generation of insights, and opening up opportunities to anticipate issues with unprecedented precision. They’re also sharing risk.

Health Care 8

Health Care Pharmaceuticals Information Technology Supply Chain 8

Harvard Business Review

MAY 10, 2016

Our experience with many global companies across industries and sectors has revealed a framework for pursuing growth through acquisition that lowers risks and helps beat the odds. Gillette introduced new shave lotions, deodorants, and shower gels for men using P&G’s soap, lotion, and antiperspirant technology and expertise.

Strategy 8

Strategy Company Biotechnology Franchising 8

Harvard Business Review

OCTOBER 22, 2013

When we surveyed over 300 global executives between 2008 and 2009, one of the primary concerns they expressed was their inability to compete long term without a solid innovation engine that can grow their top line. Develop Creative Discontent. Three major factors drive convergence: technology, competition, and the customer.

Skills 8

Skills Power Six Sigma Disruptive Innovation 8

Harvard Business Review

NOVEMBER 29, 2016

The emergence of big data, as well as advancements in data science approaches and technology, is providing pharmaceutical companies with an opportunity to gain novel insights that can enhance and accelerate drug development.

Pharmaceuticals 8

Pharmaceuticals Incubator Health Care Biotechnology 8

Harvard Business Review

MAY 28, 2013

In one of the most comprehensive global surveys of corporate directors to date, we found that they were very worried about developing and enacting strategic plans that will enable their organizations to succeed. Not innovation, risk management, technology, debt, or the regulatory environment. Not competitive threats.

Talent Management 8

Talent Management Company Telecommunications Management 8

Harvard Business Review

APRIL 19, 2016

In virtually every advanced field, whether it’s information technology, biotechnology, agriculture, or renewable energy, America holds a leading position. Take a look at any significant innovation, such as an iPhone , and you’ll find that most, if not all, of the technology came from some government program.

Innovation 8

Innovation Company Competitive Advantage Venture Funding 8

Harvard Business Review

JULY 22, 2015

division of the Korean conglomerate Hanguk Industries, where Mark, a vice president of technology, reported to him. ” Hanguk was a large, fast-growing company with diversified interests spanning electronics, biotechnology, shipping, construction, and chemicals. I’ll have 25 developers reporting to me.”

Case Study 8

Case Study Career Biotechnology Course 8

Harvard Business Review

JUNE 12, 2012

Paul Kennedy's seminal Rise and Fall of the Great Powers captures the way technological and economic advances have converted into strategic advantage, and how failure to "lock in" that edge accelerates imperial decline. Technik , then, is the technological quotient of civilization. It pledges $1.5 The contrast between the U.N.'s

First-mover Advantage 9

First-mover Advantage GDP Technology Biotechnology 9

Harvard Business Review

NOVEMBER 9, 2016

However, I fear that Mexico continuing its existing trade-based economic strategy will not necessarily produce different results in the long term — as it wouldn’t for any other developing country. That’s how they climb the global value chain. When the U.S.

Cooper 14

Cooper Long-term Industry Health Care 14

Harvard Business Review

AUGUST 23, 2016

Democrats are less pessimistic about the economy: 10% of Democrats expect a global economic slowdown in the next three years, compared to 18% of Republicans. Meanwhile, Democrats place greater importance on technology expertise and risk management. Alongside these commonalities, we also found some notable partisan differences.

Politics 8

Politics Committee Telecommunications Diversity 8